🇺🇸 FDA
Patent

US 8350042

Antiviral compounds for the treatment of HCV infection

granted A61PA61P31/14

Quick answer

US patent 8350042 (Antiviral compounds for the treatment of HCV infection) held by The Regents of the University of California expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
38
CPC classes
A61P, A61P31/14